Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Peter W Iii Rodino is COO, Secretary, Gen. Counsel at Aim Immunotech. OQRO lists 1 transaction filed with the SEC under this name, the latest on Apr 4, 2025, each linked to the official Form 4.
COO, Secretary, Gen. Counsel
Disclosures on record
1
Companies involved
1
Apr 4, 2025Bought~$44
DetailsOfficial recordAs of the latest filing on , Peter W Iii Rodino reported holding 401,762 shares of Aim Immunotech (AIM), worth about $58K at the last close of $0 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Aim Immunotech AIM | 401,762 | 402K direct | $0 | $58K | Apr 4, 2025 |
Is this Peter W Iii Rodino’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Peter W Iii Rodino bought shares on the open market in 2017, 2019, 2023, 2024 and 2025.
Peter W Iii Rodino reported 6 open-market purchases and 0 sales since 2017; purchases in 5 different years, most recently 2025.
| Year | Bought | Sold |
|---|---|---|
| 2025 | $441×1 trade | — |
| 2024 | $25K2×2 trades | — |
| 2023 | $25K1×1 trade | — |
| 2019 | $35K1×1 trade | — |
| 2017 | $10K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Apr 4, 2025, Peter W Iii Rodino reported holding 401,762 shares of Aim Immunotech (AIM). At the last close of $0 on Nov 13, 2026, that is about $58K. This is the stake disclosed in filings, not a net worth.
Peter W Iii Rodino bought shares on the open market in 2017, 2019, 2023, 2024 and 2025.
In SEC filings since 2017: the latest open-market purchase is from 2025; no open-market sale is on record.
Aim Immunotech (AIM), from 2017 to 2025: 6 purchases and 0 sales.
Peter W Iii Rodino reported 6 open-market purchases and 0 sales here, 2017 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.